User contributions for Jonathan Reyes

A user with 4 edits. Account created on 26 April 2024.
Jump to navigation Jump to search
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽

31 October 2024

27 May 2024

  • 23:4723:47, 27 May 2024 diff hist −25 Template:JR No edit summary current
  • 23:4223:42, 27 May 2024 diff hist +627 N Evinacumab-dgnb Created page with "{{DrugProjectFormSinglePage |authorTag={{JR}} |genericName=evinacumab-dgnb |aOrAn=an |drugClass=angiopoietin-like 3 (ANGPTL3) inhibitor |indicationType=treatment |indication=Evanicumab-dgnb is an angiopoietin-like 3 (ANGPTL3) inhibitor that is FDA approved for the treatment of an adjunct to other low-density lipoproteincholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 5 years and older, with homozygous familial hypercholestero..." current
  • 22:5922:59, 27 May 2024 diff hist +69 N Template:JR Created page with "Jonathan Reyes, M.D.[jona3098reyes@gmail.com]"